Medical Oncology literature, filtered by journal quality.

Scienda scans PubMed for new Medical Oncology articles and delivers one concise email — ranked by the journal's scientific standing, split across 12 topics you choose from. Daily or weekly.

See what it found last night your medical oncology topics, your quality bar — no sign-up

Every article carries its journal's rank — Elite Top 5% Top 10% Top 25% Top 50% Unranked set the minimum quality independently for each topic

…and its article type — Basic / translational research Clinical trial Guidelines Meta-analysis / Systematic review Narrative review Observational study choose the types you want, topic by topic

Medical Oncology — what you can follow

12 topics · set quality and article types on each

Thoracic Oncology (Lung, Mesothelioma)
Breast Cancer
GI Luminal Cancers (Colorectal, Gastroesophageal)
Hepatopancreatobiliary Cancers (Liver, Pancreas, Biliary)
Genitourinary Cancers (Prostate, Kidney, Bladder, Testis)
Gynecologic Cancers (Ovary, Uterus, Cervix)
Head & Neck Cancers
Melanoma & Skin Cancers
CNS & Brain Tumors
Sarcomas, Neuroendocrine & Rare Tumors
Immunotherapy, Targeted Therapy & Biomarkers (cross-tumor)
Supportive Care & Precision Oncology

Follow Medical Oncology in your inbox.

€4.50 / month or €45 / year · free trial — 30 days without a card, 60 days with · cancel any time

Start free — 30 days, no card or 60 days with a card already invited? sign in

What a digest looks like sample issue · real articles · medical oncology

Thoracic Oncology (Lung)

Major general journal: Daraxonrasib for previously treated RAS-mutant non-small-cell lung cancer

N Engl J Med · Elite · Clinical trial

Immunotherapy & Targeted Therapy

Ivonescimab plus chemotherapy in EGFR-mutated NSCLC after progression on an EGFR tyrosine kinase inhibitor (HARMONi): a phase 3 trial

Lancet Oncol · Top 5% · Clinical trial

Hematologic Malignancies

Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2)

Lancet Haematol · Top 5% · Clinical trial

Hepatopancreatobiliary Cancers

Emerging strategies for hepatocellular carcinoma surveillance: abbreviated MRI, biomarkers and benefit stratification

J Hepatol · Top 5% · Narrative review

Now see it on your own topics →

Pick your medical oncology topics and your quality bar, and see the articles Scienda actually found last night. No sign-up, no email.

Other specialties

One email. Your Medical Oncology topics. Your quality bar.

Start free — 30 days, no card or 60 days with a card already invited? sign in

€4.50 / month or €45 / year · free trial — 30 days without a card, 60 days with · cancel any time

Full pricing and what is included